BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18042384)

  • 1. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
    Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides.
    Smaine FZ; Winum JY; Montero JL; Regainia Z; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5096-100. PubMed ID: 17646100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II.
    Carta F; Maresca A; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem; 2009 Oct; 17(20):7093-9. PubMed ID: 19773173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
    Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
    Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F; Garaj V; Maresca A; Wagner J; Avvaru BS; Robbins AH; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 May; 19(10):3105-19. PubMed ID: 21515057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
    Turkmen H; Durgun M; Yilmaztekin S; Emul M; Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jan; 15(2):367-72. PubMed ID: 15603956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
    Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
    Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
    Tarko L; Supuran CT
    Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
    Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
    J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.